Skip to main content
. Author manuscript; available in PMC: 2024 Nov 1.
Published in final edited form as: Clin Microbiol Infect. 2023 Jul 31;29(11):1450.e1–1450.e7. doi: 10.1016/j.cmi.2023.07.026

Figure 3: Cumulative incidence plots of time to HHV-6 testing and detection.

Figure 3:

A: Cumulative incidence curves of time to HHV-6 testing within 100 days from HCT, treating death and subsequent HCT as competing risks and stratified by cohort. Cumulative incidence rates with 95% confidence intervals (CI) within 100 days from HCT: 17% (95% CI: 13–21%) in the pre-LTV cohort and 13% (95% CI: 10–16%) in the post-LTV cohort. B: Cumulative incidence curves of time to HHV-6 detection within 100 days from HCT, treating death and subsequent HCT as competing risks and stratified by cohort. Cumulative incidence rates with 95% confidence intervals (CI) within 100 days from HCT: 3% (95% CI: 1–5%) in both cohorts.